Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abbvie Inc shares valued at $49,497,875 were sold by GONZALEZ RICHARD A on Jul 17 ’24. At $175.00 per share, GONZALEZ RICHARD A sold 282,845 shares. The insider’s holdings dropped to 513,099 shares worth approximately $97.34 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Donoghoe Nicholas sold 21,082 shares, netting a total of over 3,716,757 in proceeds. Following the sale of shares at $176.30 each, the insider now holds 55,903 shares.
Before that, Stewart Jeffrey Ryan had sold 58,949 shares from its account. In a trade valued at $10,539,508, the EVP, CHIEF COMMERCIAL OFFICER traded Abbvie Inc shares for $178.79 each. Upon closing the transaction, the insider’s holdings decreased to 58,949 shares, worth approximately $11.56 million.
As published in a research note from HSBC Securities on June 05, 2024, Abbvie Inc [ABBV] has been rated up from a Hold to a Buy and the price target has been revised to $185. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid May. As of January 29, 2024, William Blair has increased its “Mkt perform” rating to a “an Outperform” for ABBV. Earlier on December 18, 2023, HSBC Securities downgraded its rating. Their new recommendation was “a Hold” for ABBV stock which previously was a “a Buy”.
Analyzing ABBV Stock Performance
During the last five days, there has been a surge of approximately 4.14%. Over the course of the year, Abbvie Inc shares have jumped approximately 22.42%. Shares of the company reached a 52-week high of $190.97 on 08/01/24 and a 52-week low of $153.58 on 05/30/24. A 50-day SMA is recorded $169.39, while a 200-day SMA reached $163.26. Nevertheless, trading volume fell to 6.47 million shares from 6.41 million shares the previous day.
Support And Resistance Levels for Abbvie Inc (ABBV)
According to the 24-hour chart, there is a support level at 187.33, which, if violated, would cause prices to drop to 184.95. In the upper region, resistance lies at 191.53. The next price resistance is at 193.35. RSI (Relative Strength Index) is 70.84 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 9.41, which suggests the price will increase in the coming days. Percent R is at 5.31%, indicating bullish price movement. Stochastics%K at selling indicates that the stock is to be held.
